The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Liposomes for Enhanced Bioavailability of Water-Insoluble Drugs: In Vivo Evidence and Recent Approaches
Open accessAbstract
It has been known that a considerable number of drugs in clinical use or under development are water-insoluble drugs with poor bioavailability (BA). The liposomal delivery system has drawn attention as one of the noteworthy approaches to increase dissolution and subsequently absorption in the gastrointestinal (GI) tract because of its biocompatibility and ability to encapsulate hydrophobic molecules in the lipid domain. However, there have been several drawbacks, such as structural instability in the GI tract and poor permeability across intestinal epithelia because of its relatively large size. In addition, there have been no liposomal formulations approved for oral use to date, despite the success of parenteral liposomes. Nevertheless, liposomal oral delivery has resurged with the rapid increase of published studies in the last decade. However, it is discouraging that most of this research has been in vitro studies only and there have not been many water-insoluble drugs with in vivo data. The present review focused on the in vivo evidence for the improved BA of water-insoluble drugs using liposomes to resolve doubts raised concerning liposomal oral delivery and attempted to provide insight by highlighting the approaches used for in vivo achievements.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839 · cited 2×
“Cholesterol (CH) can also be easily incorporated into the liposomal membrane in the same manner as the plasma membrane and stabilize the membrane modulating drug release, as presented in Figure 3 [6].”
BackgroundGelderblom, H., Verweij, J., Nooter, K., & Sparreboom, A. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00171-x · Cited by 1,655
Insoluble drug delivery strategies: review of recent advances and business prospects
Kalepu, S., & Nekkanti, V. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.07.003 · Cited by 1,410
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
Schachter, M. (2005) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2004.00299.x · Cited by 1,211
Strumberg, D., Richly, H., Hilger, R. A., Schleucher, N., Korfee, S., Tewes, M., Faghih, M., Brendel, E., Voliotis, D., Haase, C. G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.124 · Cited by 872
Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals
Homayun, B., Lin, X., & Choi, H.-J. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11030129 · Cited by 837
Křížová, L., Dadáková, K., Kašparovská, J., & Kašparovský, T. (2019) · Molecules · doi:10.3390/molecules24061076 · Cited by 692
Adapting liposomes for oral drug delivery
He, H., Lu, Y., Qi, J., Zhu, Q., Chen, Z., & Wu, W. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.06.005 · Cited by 663
Clinical pharmacokinetics of tyrosine kinase inhibitors
van Erp, N. P., Gelderblom, H., & Guchelaar, H.-J. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.08.004 · Cited by 503
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
Federico, A., Dallio, M., & Loguercio, C. (2017) · Molecules · doi:10.3390/molecules22020191 · Cited by 492
PEGylation for enhancing nanoparticle diffusion in mucus
Huckaby, J. T., & Lai, S. K. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.08.010 · Cited by 461
50 years of oral lipid-based formulations: provenance, progress and future perspectives
Feeney, O. M., Crum, M. F., McEvoy, C. L., Trevaskis, N. L., Williams, H. D., Pouton, C. W., Charman, W. N., Bergström, C. A. S., & Porter, C. J. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.007 · Cited by 426
Choi, Y. H., & Han, H.-K. (2018) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0370-4 · Cited by 406
Frey, A., Giannasca, K. T., Weltzin, R., Giannasca, P. J., Reggio, H., Lencer, W. I., & Neutra, M. R. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1045 · Cited by 401
Liposomal Delivery Systems: Design Optimization and Current Applications
Abu Lila, A. S., & Ishida, T. (2017) · Biological & Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00624 · Cited by 382
Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening
Yeh, T.-H., Hsu, L.-W., Tseng, M. T., Lee, P.-L., Sonjae, K., Ho, Y.-C., & Sung, H.-W. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.056 · Cited by 379
Tsuda, T. (2018) · Food & Function · doi:10.1039/c7fo01242j · Cited by 367
BCS class IV drugs: Highly notorious candidates for formulation development
Ghadi, R., & Dand, N. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.014 · Cited by 361
Xu, X.-Y., Meng, X., Li, S., Gan, R.-Y., Li, Y., & Li, H.-B. (2018) · Nutrients · doi:10.3390/nu10101553 · Cited by 358
A comprehensive review on recent preparation techniques of liposomes
Has, C., & Sunthar, P. (2020) · Journal of Liposome Research · doi:10.1080/08982104.2019.1668010 · Cited by 357
Elmeliegy, M., Vourvahis, M., Guo, C., & Wang, D. D. (2020) · Clinical Pharmacokinetics · doi:10.1007/s40262-020-00867-1 · Cited by 323
Setchell, K. D., Faughnan, M. S., Avades, T., Zimmer-Nechemias, L., Brown, N. M., Wolfe, B. E., Brashear, W. T., Desai, P., Oldfield, M. F., Botting, N. P., et al. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.2.411 · Cited by 320
Mucoadhesive vs. mucopenetrating particulate drug delivery
Netsomboon, K., & Bernkop-Schnürch, A. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.11.003 · Cited by 318
Telange, D. R., Patil, A. T., Pethe, A. M., Fegade, H., Anand, S., & Dave, V. S. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.12.009 · Cited by 309
Chen, Y., Lu, Y., Chen, J., Lai, J., Sun, J., Hu, F., & Wu, W. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.022 · Cited by 274
Drover, D. R. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443040-00002 · Cited by 248
Niu, M., Lu, Y., Hovgaard, L., Guan, P., Tan, Y., Lian, R., Qi, J., & Wu, W. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.02.009 · Cited by 248
Lee, M.-K., Lim, S.-J., & Kim, C.-K. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.01.014 · Cited by 248
Self-citationRecent Advances in Liposome Surface Modification for Oral Drug Delivery
Nguyen, T. X., Huang, L., Gauthier, M., Yang, G., & Wang, Q. (2016) · Nanomedicine · doi:10.2217/nnm.16.9 · Cited by 235
Formulation Strategies for Enhancing the Bioavailability of Silymarin: The State of the Art
Di Costanzo, A., & Angelico, R. (2019) · Molecules · doi:10.3390/molecules24112155 · Cited by 219
The Drug Transporter−Metabolism Alliance: Uncovering and Defining the Interplay
Benet, L. Z. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900253n · Cited by 205
Wu, J.-W., Lin, L.-C., Hung, S.-C., Chi, C.-W., & Tsai, T.-H. (2007) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2007.06.026 · Cited by 189
Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel
Jain, S., Kumar, D., Swarnakar, N. K., & Thanki, K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.026 · Cited by 188
Liu, W., Ye, A., Han, F., & Han, J. (2019) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2018.11.007 · Cited by 188
Hamed, R., Awadallah, A., Sunoqrot, S., Tarawneh, O., Nazzal, S., AlBaraghthi, T., Al Sayyad, J., & Abbas, A. (2016) · AAPS PharmSciTech · doi:10.1208/s12249-015-0365-2 · Cited by 183
Hu, S., Niu, M., Hu, F., Lu, Y., Qi, J., Yin, Z., & Wu, W. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.10.025 · Cited by 180
Pharmacokinetics of Selective Estrogen Receptor Modulators
Morello, K. C., Wurz, G. T., & DeGregorio, M. W. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342040-00004 · Cited by 174
Enhancing Curcumin Oral Bioavailability Through Nanoformulations
Ipar, V. S., Dsouza, A., & Devarajan, P. V. (2019) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-019-00545-z · Cited by 169
Microscopy imaging of liposomes: From coverslips to environmental SEM
Bibi, S., Kaur, R., Henriksen‐Lacey, M., McNeil, S. E., Wilkhu, J. S., Lattmann, E., Christensen, D., Mohammed, A. R., & Perrie, Y. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.12.021 · Cited by 166
Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles
Li, M., Zou, P., Tyner, K., & Lee, S. (2017) · The AAPS Journal · doi:10.1208/s12248-016-0010-3 · Cited by 165
An update on vinpocetine: New discoveries and clinical implications
Zhang, Y.-S., Li, J.-D., & Yan, C. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.11.041 · Cited by 163
Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt
Wu, W., Guan, P., & Wu, W. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s19259 · Cited by 160
Nanoparticles containing insoluble drug for cancer therapy
Guo, S., & Huang, L. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.10.002 · Cited by 159
Bhatt, P., Lalani, R., Vhora, I., Patil, S., Amrutiya, J., Misra, A., & Mashru, R. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.11.048 · Cited by 159
YANYU, X., YUNMEI, S., ZHIPENG, C., & QINENG, P. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.03.037 · Cited by 148
Behaviour of liposomes loaded with bovine serum albumin during in vitro digestion
Liu, W., Ye, A., Liu, W., Liu, C., Han, J., & Singh, H. (2014) · Food Chemistry · doi:10.1016/j.foodchem.2014.11.108 · Cited by 143
Chen, D., Xia, D., Li, X., Zhu, Q., Yu, H., Zhu, C., & Gan, Y. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.04.002 · Cited by 141
Li, C., Zhang, Su, Feng, Long, & Chen (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s38043 · Cited by 135
Bioinspired Core–Shell Nanoparticles for Hydrophobic Drug Delivery
Yang, G., Liu, Y., Wang, H., Wilson, R. J., Hui, Y., Yu, L., Wibowo, D., Zhang, C., Whittaker, A. K., Middelberg, A. P. J., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201908357 · Cited by 135
Kokkona, M., Kallinteri, P., Fatouros, D. G., & Antimisiaris, S. G. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00064-0 · Cited by 133
Wang, J., Kong, M., Zhou, Z., Yan, D., Yu, X., Cheng, X., Feng, C., Liu, Y., & Chen, X. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.10.021 · Cited by 133
Recent approaches of lipid-based delivery system for lymphatic targeting via oral route
Chaudhary, S., Garg, T., Murthy, R. S. R., Rath, G., & Goyal, A. K. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2014.950664 · Cited by 132
A pH‐Responsive Drug‐Delivery Platform Based on Glycol Chitosan–Coated Liposomes
Yan, L., Crayton, S. H., Thawani, J. P., Amirshaghaghi, A., Tsourkas, A., & Cheng, Z. (2015) · Small · doi:10.1002/smll.201501412 · Cited by 131
Hashemzadeh, H., Javadi, H., & Darvishi, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-58730-z · Cited by 128
Biopharmaceutical aspects and implications of excipient variability in drug product performance
Zarmpi, P., Flanagan, T. R., Meehan, E. J., Mann, J., & Fotaki, N. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.11.004 · Cited by 127
Bioavailability enhancement of zaleplon via proliposomes: Role of surface charge
Janga, K. Y., Jukanti, R., Velpula, A., Sunkavalli, S., Bandari, S., Kandadi, P., & Veerareddy, P. R. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.10.010 · Cited by 126
Sahariah, P., Gaware, V. S., Lieder, R., Jónsdóttir, S., Hjálmarsdóttir, M. Á., Sigurjónsson, Ó. E., & Másson, M. (2014) · Marine Drugs · doi:10.3390/md12084635 · Cited by 122
Binding of Chitosan to Phospholipid Vesicles Studied with Isothermal Titration Calorimetry
Mertins, O., & Dimova, R. (2011) · Langmuir · doi:10.1021/la200553t · Cited by 122
Liposomal drug product development and quality: current US experience and perspective
Kapoor, M., Lee, S. L., & Tyner, K. M. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0049-9 · Cited by 116
The potential use of receptor-mediated endocytosis for oral drug delivery
Russell-Jones, G. J. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00131-p · Cited by 115
Wang, X., Fan, J.-M., Liu, Y., Zhao, B., Jia, Z., & Zhang, Q. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.003 · Cited by 115
N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin
Chen, H., Wu, J. H., Sun, M. H., Guo, C., Yu, A., Cao, F., Zhao, L., Tan, Q., & Zhai, G. (2011) · Journal of Liposome Research · doi:10.3109/08982104.2011.621127 · Cited by 111
Basavaraj, S., & Betageri, G. V. (2014) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2013.12.003 · Cited by 110
Proliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivo
Chu, C., Tong, S., Xu, Y. D., Wang, L., Fu, M., Ge, Y., Yu, J., & Xu, X. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.25 · Cited by 110
Recent progress in protein and peptide delivery by noninvasive routes.
Wearley, L. L. (1991) · PubMed · Cited by 109
Babadi, D., Dadashzadeh, S., Osouli, M., Daryabari, M. S., & Haeri, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.041 · Cited by 108
Solomon, D., Gupta, N., Mulla, N. S., Shukla, S. K., Guerrero, Y. A., & Gupta, V. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0142-0 · Cited by 106
Multifaceted applications of bile salts in pharmacy: an emphasis on nanomedicine
Elnaggar, Y. S. R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s82558 · Cited by 105
Intestinal absorption of insulin nanoparticles: Contribution of M cells
Lopes, M., Abrahim, B. A., Cabral, L. M., Rodrigues, C. R., Seiça, R. M. F., Veiga, F., & Ribeiro, A. J. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.02.014 · Cited by 103
Xu, H., He, L., Nie, S., Guan, J., Zhang, X., Yang, X., & Pan, W. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.07.014 · Cited by 96
Ogawa, R., Stachnik, J. M., & Echizen, H. (2014) · Clinical Pharmacokinetics · doi:10.1007/s40262-014-0189-3 · Cited by 90
Utilization of chitosan-caged liposomes to push the boundaries of therapeutic delivery
Alavi, S., Haeri, A., & Dadashzadeh, S. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.10.063 · Cited by 90
Granito, A., Marinelli, S., Negrini, G., Menetti, S., Benevento, F., & Bolondi, L. (2015) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x15618129 · Cited by 88
Tian, M.-P., Song, R.-X., Wang, T., Sun, M., Liu, Y., & Chen, X. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.08.146 · Cited by 82
Wu, W., Lü, Y., & Qi, J. (2015) · Therapeutic Delivery · doi:10.4155/tde.15.69 · Cited by 80
Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation
Lim, S., Hong, S.-S., Choi, J. Y., Kim, J. O., Lee, M.-K., & Kim, S. H. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s113723 · Cited by 80
Self-citationRussell-Jones, G. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00127-7 · Cited by 77
QbD based development of proliposome of lopinavir for improved oral bioavailability
Patel, G. M., Shelat, P., & Lalwani, A. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.08.057 · Cited by 76
Zhao, M., Lee, S. H., Song, J. G., Kim, H. Y., & Han, H. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.04.020 · Cited by 76
Ran, R., Wang, H., Liu, Y., Hui, Y., Sun, Q., Seth, A., Wibowo, D., Chen, D., & Zhao, C. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.06.017 · Cited by 75
Stillhart, C., Dürr, D., & Kuentz, M. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23892 · Cited by 68
Inhibitory Effects of Commonly Used Excipients on P-Glycoprotein in Vitro
Gurjar, R., Chan, C. Y. S., Curley, P., Sharp, J., Chiong, J., Rannard, S. P., Siccardi, M., & Owen, A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00482 · Cited by 67
Physical stability of different liposome compositions obtained by extrusion method
Armengol, X., & Estelrich, J. (1995) · Journal of Microencapsulation · doi:10.3109/02652049509006783 · Cited by 65
Kang, Y., Ryu, M., Park, S. H., Kim, J. G., Kim, J. W., Cho, S.-H., Park, Y.-I., Park, S. R., Rha, S. Y., Kang, M. J., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy055 · Cited by 64
Phospholipid-based solid drug formulations for oral bioavailability enhancement: A meta-analysis
Fong, S. Y. K., Brandl, M., & Bauer‐Brandl, A. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.08.005 · Cited by 63
Efficacy and tissue distribution of DHP107, an oral paclitaxel formulation
Hong, J. W., Lee, I., Kwak, Y. H., Park, Y., Sung, H. C., Kwon, I. C., & Chung, H. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0261 · Cited by 63
Rethinking carbamazepine oral delivery using polymer-lipid hybrid nanoparticles
da Ana, R., Mendes, M., Sousa, J., Pais, A. A. C. C., Falcão, A. C., Fortuna, A. C., & Vitorino, C. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.11.028 · Cited by 63
Preparation, Characterization, and Stability of Liposome-Based Formulations of Mitoxantrone
Ugwu, S. O., Zhang, A. W., Parmar, M. M., Miller, B., Sardone, T., Peikov, V. T., & Ahmad, I. (2005) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-200047850 · Cited by 61
Li, R., Eun, J. S., & Lee, M.-K. (2011) · Archives of Pharmacal Research · doi:10.1007/s12272-011-0220-2 · Cited by 51
Self-citationDash, R. P., Srinivas, N. R., & Babu, R. J. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1640722 · Cited by 48
Inter-patient variability in docetaxel pharmacokinetics: A review
Nieuweboer, A. J. M., de Morrée, E. S., de Graan, A. M., Sparreboom, A., de Wit, R., & Mathijssen, R. H. J. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.04.012 · Cited by 47
Nekkanti, V., Rueda, J., Wang, Z. K., & Betageri, G. V. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.03.065 · Cited by 47
Formulation and evaluation of spray dried liposomes of lopinavir for topical application
Maniyar, M. G., & Kokare, C. (2018) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-018-0403-7 · Cited by 47
Effectiveness of submicronized chitosan-coated liposomes in oral absorption of indomethacin
Sugihara, H., Yamamoto, H., Kawashimà, Y., & Takeuchi, H. (2012) · Journal of Liposome Research · doi:10.3109/08982104.2011.621128 · Cited by 46
Ghassemi, S., Haeri, A., Shahhosseini, S., & Dadashzadeh, S. (2018) · AAPS PharmSciTech · doi:10.1208/s12249-018-1118-9 · Cited by 46
Yanamandra, S., Venkatesan, N., Kadajji, V. G., Wang, Z. K., Issar, M., & Betageri, G. V. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.08.008 · Cited by 37
Preparation, characterization, and pharmacokinetics of liposomal docetaxel for oral administration
Kim, J. H., Shin, D. H., & Kim, J.-S. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1046-y · Cited by 37
Preparation and Pharmacokinetic Study of Daidzein Long-Circulating Liposomes
Wang, Q., Liu, W., Wang, J., Liu, H., & Chen, Y. (2019) · Nanoscale Research Letters · doi:10.1186/s11671-019-3164-y · Cited by 36
Jang, Y., Chung, H. J., Hong, J. W., Yun, C., & Chung, H. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.105 · Cited by 32
Deng, J. G., Zhang, Z., Liu, C., Yin, L., Zhou, J., & Lv, H. (2015) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12448 · Cited by 31
Weinheimer, M., Fricker, G., Burhenne, J., Mylius, P., & Schubert, R. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.08.055 · Cited by 30
Design, Characterization, and In Vivo Pharmacokinetics of Tacrolimus Proliposomes
Nekkanti, V., Rueda, J., Wang, Z. K., & Betageri, G. V. (2015) · AAPS PharmSciTech · doi:10.1208/s12249-015-0428-4 · Cited by 29
Youssef, S. F., Elnaggar, Y. S. R., & Abdallah, O. Y. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0238 · Cited by 28
Tian, J.-N., Ge, B.-Q., Shen, Y.-F., He, Y., & Chen, Z. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b05547 · Cited by 25
Brocks, D. R., & Betageri, G. V. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702320266190 · Cited by 23
Tong, S., Chu, C., Wei, Y., Wang, L., Gao, X., Xu, X., & Yu, J. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01210.x · Cited by 22
Kovvasu, S. P., Kunamaneni, P., Yeung, S., Rueda, J., & Betageri, G. V. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1437-5 · Cited by 13
Choi, M. S., Kim, Y. C., & Maeng, H. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-019-00429-z · Cited by 10
Review of solubilization techniques for a poorly water-soluble drug: carbamazepine.
Kumar, M. P., Kumar, G. Y. S., Apte, S., & Rao, Y. M. (2016) · PubMed · Cited by 4
Cited by
Advances in Oral Drug Delivery
Alqahtani, M. S., Kazi, M., Alsenaidy, M. A., & Ahmad, M. Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.618411 · Cited by 876
Lombardo, D., & Kiselev, M. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030543 · Cited by 718
Cimino, C., Maurel, O. M., Musumeci, T., Bonaccorso, A., Drago, F., Souto, E. M. B., Pignatello, R., & Carbone, C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030327 · Cited by 324
Ajeeshkumar, K. K., Aneesh, P. A., Raju, N., Suseela, M., Ravishankar, C. N., & Benjakul, S. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12725 · Cited by 283
Pande, S. (2023) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2023.2247036 · Cited by 258
Metadata
- Authors
- Lee, M.-K.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2020-03-13
- Volume
- 12
- Issue
- 3
- Pages
- 264
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W3011439989
- Cited by
- 335
- References
- 109
- FWCI
- 13.13
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.